Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Stocks On The Rise: ARWR, COOL, MRNS, QURE

Published 07/03/2018, 12:19 AM
Updated 07/09/2023, 06:31 AM

Swing trade Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) is doing great, popping 1.27, or 9.34%, to 14.87, on 2.6 million shares on Monday. Its chart continues to look phenomenal. So, either it holds right there and pulls back, or it accelerates, which may very well be what’s taking place. If it ramps and starts to move up, look for 17, and then 20-21. We don’t want this stock underneath 12 1/2.

PolarityTE Inc (NASDAQ:COOL) had a nice snapback day on Monday, jumping 2.54, or 11%, to 26.08, on 911,300 shares traded off of key support. What I like about Monday is that although the volume wasn’t great, it was still up 911,300, which was extremely strong volume for this stock for the last 3-4 weeks. The 29-30 zone is key resistance. Monday’s action took it back above resistance, above the 50, and I think it’s going to follow through, and at least test 28-28.40, and maybe 30, 32-3.

Marinus Pharmaceuticals, Inc. (MRNS) popped, pulled back, formed a nice wedge, and then popped and wedged again. It ran up 58 cents, or 8.2%, to 7.65, on 1 million shares on Monday. If it does take out resistance at 8 1/4, I’m looking for 10, and then 12 to be the next target.

Uniqure NV (BE:UQ1) ran 1.38, or 3.65%, to 39.18, on 193,865 shares traded on Monday. It formed a beautiful rising channel, having gone from 5.00 to 48.00 in about a year. It doesn’t look done yet. At this point, it’s over 41. We’re looking for 46 and 52.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Stocks on the long side included Applied Optoelectronics, Inc. (AAOI), Adamis Pharmaceuticals Corporation (ADMP), Arrowhead Pharmaceuticals, Inc. (ARWR), BioLife Solutions, Inc. (BLFS), PolarityTE, Inc. (COOL), eGain Corporation (EGAN), Enphase Energy, Inc. (ENPH), New Concept Energy, Inc. (GBR), Bitcoin Investment Trust (GBTC), Intercept Pharmaceuticals, Inc. (ICPT), Innovate Biopharmaceuticals, Inc. (INNT), Marinus Pharmaceuticals, Inc. (MRNS), Neptune Technologies & Bioressources Inc. (NEPT), uniQure N.V. (QURE), Sunrun Inc. (RUN), Seattle Genetics, Inc. (SGEN), and Viking Therapeutics, Inc. (VKTX).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.